Psychemedics Corporation (PMD) News
Filter PMD News Items
PMD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PMD News Highlights
- For PMD, its 30 day story count is now at 6.
- Over the past 5 days, the trend for PMD's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- LI, NOV and UL are the most mentioned tickers in articles about PMD.
Latest PMD News From Around the Web
Below are the latest news stories about PSYCHEMEDICS CORP that investors may wish to consider to help them evaluate PMD as an investment opportunity.
Psychemedics Third Quarter 2022 Earnings: US$0.02 loss per share (vs US$0.13 profit in 3Q 2021)Psychemedics ( NASDAQ:PMD ) Third Quarter 2022 Results Key Financial Results Revenue: US$6.52m (down 2.4% from 3Q... |
Psychemedics declares $0.07 dividend
|
Psychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash DividendACTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2022. The Company also announced a cash quarterly dividend of $0.07 per share payable to the shareholders of record as of December 2, 2022, to be paid on December 16, 2022. |
One Psychemedics Corporation (NASDAQ:PMD) insider upped their stake by 13% in the previous yearFrom what we can see, insiders were net buyers in Psychemedics Corporation's ( NASDAQ:PMD ) during the past 12 months... |
Don't Race Out To Buy Psychemedics Corporation (NASDAQ:PMD) Just Because It's Going Ex-DividendRegular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Psychemedics... |
Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash DividendACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2022. The Company also announced a quarterly dividend of $0.07 per share payable to the shareholders of record as of August 24, 2022, to be paid on September 9, 2022. |
Psychemedics GAAP EPS of -$0.06, revenue of $6.51MNo summary available. |
Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.’s Retirement after More than 20 Years of Dedicated ServiceACTON, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced today that it will be nominating Peter H. Kamin and Darius G. Nevin to serve as new members of its Board of Directors at its upcoming Annual Meeting of Stockholders to be held on August 12, 2022, and that Walter S. Tomenson, Jr. will be retiring from the Board as of the completion of his current term ending at the 2022 Annual Meeting. As a result of these new nominations, Mr. Tomenson’s retirement an |
Capital Allocation Trends At Psychemedics (NASDAQ:PMD) Aren't IdealWhen we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics... |
Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash DividendACTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2022, and the declaration of a cash dividend of $0.07 per share to be paid on June 24, 2022, to shareholders of record as of May 27, 2022. |